Navigating SNRI Risks and Tapering Strategies

This chapter explores the potential adverse effects of SNRIs, particularly duloxetine, detailing issues like hepatotoxicity and withdrawal symptoms. It discusses the importance of gradual tapering from these medications, monitoring patient progress, and incorporates alternative treatments such as psychotherapy and lifestyle changes. Additionally, the chapter highlights concerns regarding the use of antidepressants during pregnancy and emphasizes tailored treatment plans to ensure patient safety.